Resource Center

Stories

The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast.

These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or rescntr@ire.org) where a researcher can help you pinpoint what you need.

Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:



Search results for "drug companies" ...

  • A story of hope, and a lopsided deal

    A six-month Boston Globe investigation revealed that a contractor from California was repeatedly employing impoverished, drug-addicted men from an evangelical church to renovate hotels across the country. The story started in Boston, where reporter Casey Ross discovered that the contractor, Installations Plus, was paying illegally low wages to workers trucked up from Victory Outreach Church in Philadelphia. He also traced the illegal behavior to other Massachusetts communities and then to California, where he spent several days tracking down Victory Outreach members who recalled working for the contractor in that state. The result of his reporting was a richly detailed narrative that took readers into a little-known corner of America’s underground economy. After the story’s publication, the state of Massachusetts announced an effort to strengthen labor enforcement against companies that fund and manage projects where significant violations are found. In addition, California labor officials initiated an investigation into the employment practices of Installations Plus.

    Tags: Economy; low wages; contractor; workers

    By Reporter Casey Ross; Editors Andrew Caffrey; Shirley Leung; Mark Morrow

    Boston Globe

    2012

  • HBO Real Sports: Hockey's Darkest Day

    In 2011 a plane carrying a Russian hockey team crashed shortly after takeoff--the deadliest accident in the history of professional sports. A five-month Real Sports investigation uncovered massive safety problems in the Russian hockey league. The league spent millions on player salaries but "a few bucks" on everything else--including travel. The plane that crashed was operated by a cheap, third-rate company that had been banned from flying to Europe because they had been cited so many times for major safety violations. The crew of the plane hadn't even completed their training. Our investigation showed that the lack of safety in the world’s second best hockey league—called the KHL—often extends to the ice where KHL team doctors use IV’s and drugs to get their players to perform better on the ice. One young star died after receiving an injection of banned drugs from team doctors. When it came to travel, the lack of safe conditions was nearly universal. Practically every team flew on a Soviet-era jet—jets that make up 3% of the world’s fleet but account for 42% of the world’s accidents. These jets are in such poor condition that most Russian airlines wont use them. Yet even after the crash the KHL continued to use these planes, a fact they initially denied. Shortly after we interviewed the KHL Vice President, the league changed its rules. Now teams fly strictly on modern equipment.

    Tags: Russia; Russian hockey team; plane crash; the KHL;

    By Correspondent: Bernard Goldberg; Producers: Joe Perskie; Josh Fine; Associate Producer: Nisreen Habbal; Editor: Tres Driscoll

    HBO Sports

    2012

  • C-HIT: Pharma Perks

    The Affordable Care Act requires pharmaceutical companies to publicly report all payments to physicians by September 2013. Some drug companies have already compiled, but few consumers know that the information is available or how to access it. What this story did is disclose for the first time for CT consumers: 1) how many doctors in Connecticut are high-prescribers of certain psychotropic and pain medications, (108) 2) the cost of written prescriptions (hundreds of thousands of dollars in some cases) 3) how many of these doctors received payments from drug companies (at least 43) 4) and the amounts that the doctors received from the drug companies ($30,000 - $99,000) It also reported that only 3 doctors on the high-prescribing drug list have been disciplined by the state Medical Examining Board.

    Tags: Affordable Care Act; pharmacy; physicians; prescriptions; drugs; Medical Examining Board

    By Lisa Chedekel

    Conn. Health Investigative Team

    2012

  • Meningitis Outbreak

    When an unprecedented outbreak of fungal meningitis began last fall in Tennessee, The Tennessean reacted with aggressive and highly interactive coverage that has led the nation. Before other media realized the significance of the outbreak, which has sickened more than 650 people in 19 states, The Tennessean was already analyzing the regulation of specialty pharmacies and digging into the contracts and connections of the New England Compounding Center, the Massachusetts firm suspected of shipping contaminated steroids responsible for the illnesses. As of today, the outbreak has killed 40 people nationwide, 14 of them in Tennessee. More than a hundred more are still sick. We quickly reported problems associated with New England Compounding Center, lag times on informing victims and regulation slip-ups in the drug compounding industry that allowed companies to operate outside of the law.

    Tags: Health; meningitis; New England Compounding Center; steroids

    By Tom Wilemon, reporter; Walter F. Roche Jr., reporter; Lisa Green, health editor; Duane Marsteller, business reporter; Jessica Bliss, reporter; Josh Brown, reporter

    The Tennessean

    2012

  • Cracks in the Empire: Inside Johnson & Johnson

    Johnson & Johnson, the gold standard of corporate America for its single-minded devotion to its customers, is fending off federal, state and consumer allegations that the company harmed and cheated the ill. The Press found that the New Brunswick, NJ-based copmany set its sights in the last decade on making record profits but at a high cosst. Its main OTC pain reliever company was shut down in part for being too dirty. Thousands of hip replacement patients say the device failed inside their bodies, causing them great pain.

    Tags: Johnson & Johnson; pain relievers; drugs; pharmaceuticals

    By Michael L. Diamond; Paul D'Ambrosio

    Asbury Park Press

    2011

  • Side Effects

    "This series began in 2009 after learning that doctors at the University of Wisconsin School of Medicine had been receiving payments from drug and medical device companies. It has grown into a much broader and deeper look at the pervasive influence of money in medicine."

    Tags: FDA; Medtronic; medical research

    By John Fauber

    Milwaukee Journal Sentinel

    2011

  • Down the Hatch

    The story investigates whether a powerful drug manufacturing company lied to push an antipsychotic on foster children.

    Tags: Johnson & Johnson; foster children; schizophrenia; Risperdal

    By Craig Madison

    Village Voice Media/Houston Press

    2011

  • "Physicians on Pharma's Payroll: Educators or Marketers?"

    This story focuses on doctors as industry speakers and their relationship with pharmaceutical companies. The pharmaceutical companies claim to choose speakers based on expertise, but further investigation shows that many of the hired physicians have "serious transgressions on their state records." They also tend to be "high prescribers" of the company's products.

    Tags: pharmacy; prescriptions; Geodon; Pfizer; antipsychotic drugs; pharmaceutical companies; Department of Health; New York; Food and Drug Administration

    By Ailsa Chang; Gisele Regatao

    WNYC

    2010

  • Dollars for Docs

    The series investigates the relationship between pharmaceutical companies and the physicians they pay to serve as their speakers and consultants. ProPublica created a searchable database on its website that allows members of the public to see whether their doctors have been paid by one of seven pharmaceutical companies.

    Tags: pharmaceutical companies; drugs; drug sales; widget; speakers

    By Charles Ornstein, Tracy Weber, Dan Nguyen

    ProPublica

    2010

  • Side Effects

    The author examines the conflicts of interest within the medical community and the influence of pharmaceutical companies on doctors and researchers. The series shows the dangerous consequences that come when drug companies pay doctors and researchers to endorse their products. An inquiry by a U.S. Senate committee, as well as policy reform at the University of Wisconsin School of Medicine and Public Health were results of this investigation.

    Tags: pharmaceutical companies; drug companies; medicine; conflict of interest; doctors

    By John Fauber

    Milwaukee Journal Sentinel

    2010